Robert Thorne

Robert Thorne is currently a full-time Denali Fellow with Denali Therapeutics (Sept 2018-) and an Adjunct Associate Professor in the Department of Pharmaceutics at the University of Minnesota (Feb 2019-), following earlier service on the faculty at New York University School of Medicine (2008-2010) and the University of Wisconsin-Madison (2010-2018). His research has focused on the physiology of brain fluids, perivascular pathways for CNS biodistribution, and novel methods/routes/strategies for drug delivery to the brain and spinal cord. Dr. Thorne is the Vice President of the International Brain Barriers Society (https://www.ibbsoc.org/) and has played a major organizational role for many key meetings in the CNS barriers field, including serving as the elected Chair of the 2016 ‘Barriers of the CNS’ Gordon Research Conference.